Vaneck Pharmaceutical Etf Performance
| PPH Etf | USD 90.01 0.61 0.68% |
The entity has a beta of 0.24, which indicates not very significant fluctuations relative to the market. As returns on the market increase, VanEck Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding VanEck Pharmaceutical is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders. ...more
1 | Pharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPH - Seeking Alpha | 10/03/2024 |
2 | Twelve Points Wealth Management LLC Has 4.14 Million Holdings in VanEck Pharmaceutical ETF | 10/17/2024 |
3 | Should You Invest in the VanEck Pharmaceutical ETF | 11/11/2024 |
| In Threey Sharp Ratio | 0.38 |
VanEck |
VanEck Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 9,900 in VanEck Pharmaceutical ETF on August 30, 2024 and sell it today you would lose (899.00) from holding VanEck Pharmaceutical ETF or give up 9.08% of portfolio value over 90 days. VanEck Pharmaceutical ETF is generating negative expected returns assuming volatility of 0.6751% on return distribution over 90 days investment horizon. In other words, 6% of etfs are less volatile than VanEck, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
VanEck Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VanEck Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as VanEck Pharmaceutical ETF, and traders can use it to determine the average amount a VanEck Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2203
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PPH |
Estimated Market Risk
| 0.68 actual daily | 6 94% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average VanEck Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Pharmaceutical by adding VanEck Pharmaceutical to a well-diversified portfolio.
VanEck Pharmaceutical Fundamentals Growth
VanEck Etf prices reflect investors' perceptions of the future prospects and financial health of VanEck Pharmaceutical, and VanEck Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VanEck Etf performance.
| Price To Earning | 17.83 X | |||
| Price To Book | 2.74 X | |||
| Price To Sales | 1.14 X | |||
| Total Asset | 530.46 M | |||
About VanEck Pharmaceutical Performance
By evaluating VanEck Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into VanEck Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if VanEck Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if VanEck Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Pharmaceutical is traded on NASDAQ Exchange in the United States.| VanEck Pharmaceutical generated a negative expected return over the last 90 days | |
| Latest headline from zacks.com: Should You Invest in the VanEck Pharmaceutical ETF | |
| The fund maintains 99.86% of its assets in stocks |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in VanEck Pharmaceutical ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.